Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Sinai Health System | OTHER |
Not provided
Not provided
Not provided
Not provided
Perinatal depression occurs in 15% of pregnant women and new mothers, yet as few as 1 in 5 receive adequate treatment. It has a negative impact on the woman herself, as well as a potential for serious consequences for her child. Virtual psychiatric care is a potential model that may provide accessible mental health care during this time, as barriers to in-person care often include unpredictable infant schedules, competing childcare demands, or travel/cost challenges. The Virtual-PND intervention consists of 12-weeks of the option of supplementing in-person psychiatric care with secure, in-home real-time video-visits through the Ontario Telemedicine Network. This pilot RCT will demonstrate the feasibility of proceeding to a future large-scale RCT evaluation of virtual psychiatric care for this population.
This is a two-site pilot randomized controlled trial (RCT) to evaluate the feasibility of a Virtual Psychiatric Care for Perinatal Depression (Virtual-PND) intervention protocol, comparing virtual care to in-person care only. Participants will be pregnant or postpartum women with a major depressive disorder who are referred for care at one of the participating study sites. Each study site is a specialist reproductive psychiatric program where women from the greater Toronto area are referred, and generally treated with in-person care. Those randomized to the virtual care group will be able to receive psychiatric visits with video-based visits. Those randomized to the in-person care group will receive in-person care only, as per usual clinical practice at the study sites. The length of the active treatment phase will be 12 weeks from enrolment. The overall objective of this pilot RCT is to determine the feasibility of conducting a larger RCT to evaluate the efficacy of the treatment model, comparing outcomes among those with and without access to virtual care, and cost-effectiveness.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Virtual Psychiatric Care Group | Experimental | Participants randomized to the intervention group will have the option to receive video-based psychiatrist care in addition to care as usual. Participants will be assigned to begin immediately after randomization. |
|
| Control Group | No Intervention | Women allocated to the control condition will receive care as usual (in-person psychiatric care) from the study site to which they were referred. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Virtual Psychiatric Care | Behavioral | Virtual psychiatric care for perinatal depression will be offered to participants, in addition to care as usual, for a 12-week period by their treating perinatal psychiatrist. Virtual care will be delivered by video-based visits through the Ontario Telemedicine Network (OTN). The treating psychiatrist may request that an intervention group participant present for in-person care at any visit, and this may include need for behavioural activation, or another health-related indication at the discretion of the treating psychiatrist. |
| Measure | Description | Time Frame |
|---|---|---|
| Recruitment Feasibility (Recruitment Feasibility) | The number of women recruited to the study at each site | One year from when the study starts enrolling participants |
| Measure | Description | Time Frame |
|---|---|---|
| Edinburgh Postnatal Depressive Scale (EPDS) | The investigators will measure depressive symptoms using the EPDS, a self-report, 10-item depression screening measure that has been validated for use in pregnancy. EPDS scores >12 are predictive of a diagnosis of major depressive disorder. | At 12 weeks post-randomization |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Lori Wasserman, MD, FRCPC | Women's College Hospital | Principal Investigator |
| Ariel Dalfen, MD, FRCPC | Sinai Health System | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mount Sinai Hospital | Toronto | Ontario | M5G 1X5 | Canada | ||
| Women's College Hospital |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Behavioral: Virtual Psychiatric Care for Perinatal Depression
Not provided
Not provided
Not provided
Not provided
|
| State-Trait Anxiety Inventory (STAI) |
The investigators will measure anxious symptoms using the STAI, a self-report, 40-item anxiety screening measure that has shown good discriminate validity in perinatal populations. STAI scores >48 are predictive of having an anxiety disorder diagnosis. |
| At 12 weeks post-randomization |
| Parenting Stress Index, Short Form (PSI) | The investigators will measure stress in the parent-child relationship using the PSI short form, a 36-item measure which consists of three sub-scales. | At 12 weeks post-randomization |
| Recruitment Feasibility (Recruitment Eligibility) | The proportion of participants eligible to participate at each recruitment site | One year from when the study starts enrolling participants |
| Recruitment Feasibility (Enrollment) | Average length of time from enrollment to 1st psychiatrist visit | From enrollment to first treatment visit |
| Intervention Acceptability (Qualitative - participants) | Virtual-PND Participant Program Evaluation Questionnaire. This is comprised of Likert-type scale questions to elicit feedback on acceptability of the virtual care experience and model. | At 12 weeks post-randomization |
| Intervention Acceptability (Qualitative - physicians) | Virtual-PND Physician Program Evaluation Questionnaire. This is comprised of open and closed-ended questions to elicit feedback on the acceptability of the virtual care experience and model. | At 12 weeks post-randomization |
| Intervention Acceptability (Patient-Reported Costs) | Patient-Reported Costs Questionnaire. This is comprised of open and closed-ended questions regarding: a) time spent travelling to visits and on missed work; and b) cost of travel, food, childcare and data charges. | At 12 weeks post-randomization |
| Intervention Acceptability (Clinical visits) | Medical chart review - number of psychiatrist visits (overall, in person, and virtual), and number of minutes per visit. | Between randomization and 12 weeks post-randomization |
| Trial Protocol Adherence (Study Measure Completion) | Proportion of participants who complete follow-up measures. | At 12 weeks post-randomization |
| Toronto |
| Ontario |
| M5S 1B2 |
| Canada |